Crossmark

Enhancement of the serum chloride concentration by administration of sodium–glucose cotransporter-2 inhibitor and its mechanisms and clinical significance in type 2 diabetic patients: a pilot study

Crossref DOI link: https://doi.org/10.1186/s13098-020-0515-x

Published Online: 2020-01-13

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kataoka, Hajime

Yoshida, Yuichi
License Information

Text and Data Mining valid from 2020-01-13

Version of Record valid from 2020-01-13
More Information

Article History

Received: 26 September 2019

Accepted: 4 January 2020

First Online: 13 January 2020

Ethics approval and consent to participate, consent for publication

: The Institutional Review Board (IRB) at Nishida Hospital approved the study (No. 201611-01), and all patients provided written informed consent before participation.

: Not applicable.

: The author declares that they have no competing interests.

Document is current

Any future updates will be listed below